24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Therapix
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:57
TechnoPulm raises $2 million to develop a handheld device capable of performing full lung function tests
12:16
Bill Ackman sees 80% return on Tel Aviv Stock Exchange investment in just 10 months
11:27
After OpenAI’s wild year, three big questions linger about its future
08:53
Challenges in the data world in 2025: Can we keep up?
More stories
Buzz
Most popular
Daily
Weekly
1
Intel employees brace for layoff notices as cuts to move into high gear next week
2
"We’ll be looking out for you": Intel CEO Gelsinger stands with Israeli team
3
“We are building a payment platform fit for the post-pandemic world”
4
OpenWeb turmoil: Jeff Horing's role in ousting CEO Nadav Shoval reveals the unicorn industry's dark underbelly
5
Prime Security nets $6 million in Seed to build guardrails into the software design phase
More news
Therapix
4 stories about Therapix
Cannabis Companies Therapix and Destiny to Merge
28.07.19
|
Adi Pick
The merged company will focus on Therapix's technology and assets pertaining to clinical-stage pharmaceutical applications of cannabis, and will include Destiny's genomics-based cannabis breeding techniques and development capabilities
Cannabis Company Therapix Biosciences to Raise $2.25 Million in Direct Offering
28.03.19
|
Lilach Baumer
In December, Israel-based Therapix scrapped a deal to be acquired by Canadian FSD Pharma for $48 million worth of FSD stock
FSD Pharma’s Acquisition of Therapix Hits a Snag
12.12.18
|
Tzally Greenberg
In October, FSD agreed to buy Therapix for $48 million in stock, but a Tuesday filing by Therapix revealed that the companies have returned to the negotiating table
FSD Pharma Co-Chairman on Where the Cannabis Industry Is Headed
28.11.18
|
Tzally Greenberg
On a visit to Israel, the co-chairman of the company said he believes cannabis research is going to come from Israel and Australia. He expects China to become a significant player in the cannabis market
Please ensure Javascript is enabled for purposes of
website accessibility